These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Phase II trial with bleomycin, CCNU, and streptozotocin in patients with metastatic cancer of the breast. Band PR, Canellos GP, Sears M, Israel L, Pocock SJ. Cancer Treat Rep; 1977 Oct; 61(7):1365-7. PubMed ID: 73416 [No Abstract] [Full Text] [Related]
5. Adriamycin and CCNU in the treatment of advanced breast cancer. Muss HB, White DR, Richards F, Cooper MR, Spurr CL. Cancer Treat Rep; 1976 Nov; 60(11):1687-9. PubMed ID: 1021240 [No Abstract] [Full Text] [Related]
6. Combination chemotherapy for disseminated carcinoma of the breast. Lozada JA, Grillo-López A, Vélez-Garciá E. Bol Asoc Med P R; 1975 Jun; 67(6):157-63. PubMed ID: 1055588 [No Abstract] [Full Text] [Related]
7. Chemotherapy of breast cancer. Mitchell MS. Conn Med; 1975 Jan; 39(1):4-5. PubMed ID: 1109851 [No Abstract] [Full Text] [Related]
12. Use of combination chemotherapy with CCNU, bleomycin, and vincristine in the treatment of metastatic melanoma in patients resistant to DTIC therapy. Everall JD, Dowd PM. Cancer Treat Rep; 1979 Jan; 63(1):151-5. PubMed ID: 84710 [No Abstract] [Full Text] [Related]
13. Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast. Smalley RV, Murphy S, Huguley CM, Bartolucci AA. Cancer Res; 1976 Nov; 36(11 Pt 1):3911-6. PubMed ID: 975039 [Abstract] [Full Text] [Related]
14. Treatment of hepatic metastases from breast cancer. Bugarski M, Vuletić L, Boberić J, Milosavljević A, Dilparić S, Tomin R, Naumović P. Clin Oncol; 1978 Jun; 4(2):167-71. PubMed ID: 668248 [No Abstract] [Full Text] [Related]
15. An overview of the status of the nitrosoureas in other tumors. Carter SK. Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034 [No Abstract] [Full Text] [Related]
16. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study. Rivkin SE, Green SJ, Lew D, Costanzi JJ, Athens JW, Osborne CK, Vaughn CB, Martino S. Cancer; 2003 Jan 01; 97(1):21-9. PubMed ID: 12491501 [Abstract] [Full Text] [Related]
17. Combination chemotherapy for advanced mammary carcinoma: a twelve-year experience. Greenspan EM. Mt Sinai J Med; 1972 Jan 01; 39(5):435-46. PubMed ID: 4628078 [No Abstract] [Full Text] [Related]
18. CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma. Poplin EA, Aisner J, Van Echo DA, Whitacre M, Wiernik PH. Cancer Treat Rep; 1982 Jul 01; 66(7):1557-9. PubMed ID: 6284360 [Abstract] [Full Text] [Related]
19. [Results of 5-fluorouracil, methotrexate, cyclophosphamide and prednisone combination therapy in the treatment of advanced breast cancer]. García Puche JL, Ballesteros P, Cueto J, Mendiola C, Rodríguez PA, Talavera MC. Rev Clin Esp; 1979 Feb 15; 152(3):203-8. PubMed ID: 441472 [No Abstract] [Full Text] [Related]
20. [Adjuvant chemotherapy of primary breast cancer]. Heuson JC, Mattheiem WH. Acta Chir Belg; 1977 Feb 15; 76(4):437-43. PubMed ID: 919991 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]